| 4A9F | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | EDO, MB3, SO4 | enzyme |
| ||||||||||||
| Primary reference | Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery., Chung CW, Dean TW, Woolven JM, Bamborough P, J Med Chem. 2011 Dec 5. PMID:22136404 | ||||||||||||||
| Data retrieval |
![]() |
| View 4A9F in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |